Editor's Note: This white paper is part of the USC-Brookings Schaeffer Initiative for Health Policy, which is a partnership between the Economic Studies Program at Brookings and the USC Schaeffer Center for Health Policy & Economics. The Initiative aims to inform the national health care debate with rigorous, evidence-based analysis leading to practical recommendations using the collaborative strengths of USC and Brookings. This work was supported by Arnold Ventures.
Authors
Erin C. Fuse Brown, Loren Adler, Erin Duffy, Paul B. Ginsburg, Mark Hall, Samuel Valdez
- ACKNOWLEDGMENTS
- The authors thank Erin Trish for her intellectual contributions and Laura Alexander, David Demres, Matthew Fiedler, Bob Kocher, Richard Scheffler, and Misha Segal for helpful comments on a draft of this paper. We thank Joseph Allen, Kathleen Hannick, Mengqi Rebecca Hsu, Alex McDonald, Conrad Milhaupt, and Jake Summerlin for their research assistance and Alwyn Cassil for her editorial contributions.
- Disclosures
- This work was supported by Arnold Ventures. The funder had no involvement in the collection,analysis and interpretation of data; in the writing of the analysis; or in the decision to publish. Erin Fuse Brown is a consultant to the National Academy for State Health Policy and an Advisory Board member for Catalyst for Payment Reform. Paul Ginsburg is a Public Trustee of the American Academy of Ophthalmology and an Advisory Board member of the National Institute for Health Care Management. Other than the aforementioned, the authors did not receive financial support from any firm or person for this paper and they are currently not an officer, director, or board member of any organization with an interest in this paper.
- Published in
- United States of America
